FDA Approved: FOCALIN — Supplemental Application (Sandoz Inc)

View source ↗

Summary

The FDA approved a supplemental application for FOCALIN (dexmethylphenidate hydrochloride) submitted by Sandoz Inc, resulting in a label change for the drug.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Attention Deficit Hyperactivity Disorder

Drugs mentioned

• FOCALIN (DEXMETHYLPHENIDATE HYDROCHLORIDE)

Snippet

SUPPL AP for FOCALIN (DEXMETHYLPHENIDATE HYDROCHLORIDE)